Analytical Data
-
Gene name
PPP1R3G
- Application
-
Species
Human
-
Source
E. coli
-
Tag
N- His & C- Myc
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
B7ZBB8
-
Expression Region
1-358aa
-
Molecular Weight
45.5 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
PPP1R3G, a member of the protein phosphatase 1 regulatory subunit family, plays a crucial role in the regulation of protein phosphatase 1 (PP1) activity, which is essential for various cellular processes, including metabolism, cell division, and signal transduction. This regulatory subunit specifically modulates PP1 activity in response to different cellular signals, thereby influencing numerous cellular functions. The study of PPP1R3G is particularly significant due to its involvement in glucose homeostasis and its potential implications in metabolic disorders such as diabetes. Recent research has shown that PPP1R3G may be a key player in regulating glycogen synthesis, as it interacts with glycogen synthase and other metabolic enzymes. Understanding its structure and function can provide insights into the molecular mechanisms underlying its regulatory roles, paving the way for potential therapeutic targets in diseases linked to dysregulated metabolism. Given the rising prevalence of metabolic diseases worldwide, the development of recombinant PPP1R3G proteins for in vitro studies can facilitate a deeper understanding of its biological functions and its role in metabolic pathways. Moreover, the generation of these recombinant proteins allows for the exploration of their interactions with other cellular components, which is vital for elucidating their exact mechanisms of action within the cell. Thus, ongoing research into PPP1R3G and its regulatory pathways holds significant promise for advancing our knowledge of cellular metabolism and developing innovative strategies for treating metabolic disorders.
